Both EVPL and ENTPD3 were enriched in the regulation of immune cells and immune response, implying that immune dysfunction related to EVPL and ENTPD3 may play a crucial role in the co-development of T2DM and CRC. Here, ENTPD3 is linked to colorectal carcinoma.